This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • HIV/AIDS  • Neurology  • External Eye Disease  • Drug Therapy  • Adverse Effects  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Rona Z. Silkiss, MD; Han Lee, MD, PhD; Vincent L. Gills Ray, MD

Arch Ophthalmol. 2009;127(3):345-346.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We describe 2 patients with human immunodeficiency virus (HIV)/AIDS receiving highly active antiretroviral therapy with bilateral ptosis. In both cases, the ptosis developed during the course of the disease and its treatment. Each patient underwent surgical ptosis repair. A biopsy of the advanced levator complex, including the levator muscle, aponeurosis, and orbicularis oculi muscle, was obtained intraoperatively. This was compared with a similar biopsy taken from an HIV-negative control subject.

Report of Cases

Case 1

A 57-year-old man with a medical history of HIV/AIDS was referred for treatment of vision-impairing upper eyelid ptosis. He was treated for cytomegalovirus retinitis in his left eye 15 years prior to his initial visit to us. His HIV medications included lamivudine (Epivir; GlaxoSmithKline, Philadelphia, Pennsylvania) and didanosine (Videx; Bristol-Myers Squibb Co, New York, New York), both of which are nucleoside analogues similar to zidovudine, as well . . . [Full Text of this Article]

Case 2

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?